FDA Inspection 1216787 — AVEVA Drug Delivery Systems, Inc.

AVEVA Drug Delivery Systems, Inc. — FEI 1000307689

The FDA completed an inspection of AVEVA Drug Delivery Systems, Inc. on September 1, 2023 in Miramar, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miramar, FL (United States)

Citations

IDCFRDescription
150521 CFR 211.122(d)Label storage access limited to authorized personnel
355721 CFR 211.52Washing and toilet facilities are deficient